Edwards Lifesciences Corporation Debt Securities, Available-for-sale, Unrealized Loss Position
Edwards Lifesciences Corporation (EW) had Debt Securities, Available-for-sale, Unrealized Loss Position of $885.80 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPosition · last filed 2026-08-04
- 2026-06-30: Debt Securities, Available-for-sale, Unrealized Loss Position $885.80M.
- 2026-03-31: Debt Securities, Available-for-sale, Unrealized Loss Position $488.50M.
- 2025-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position $151.60M.
- 2025-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position $101.70M.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position | Debt Securities, Available-for-sale, Unrealized Loss Position as first filed |
|---|---|---|
| 2026-06-30 | $885.80M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $488.50M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $151.60M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $101.70M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $125.60M 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $154.40M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $222.60M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $298.60M 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $437.80M 10-Q · filed 2024-07-31 | |
| 2024-03-31 | $634.30M 10-Q · filed 2024-04-29 | |
| 2023-12-31 | $878.90M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $974.80M 10-Q · filed 2023-10-27 | |
| 2023-06-30 | $1.17B 10-Q · filed 2023-07-28 | |
| 2023-03-31 | $1.29B 10-Q · filed 2023-04-28 | |
| 2022-12-31 | $1.47B 10-K · filed 2024-02-12 | |
| 2022-09-30 | $1.63B 10-Q · filed 2022-10-28 | |
| 2022-06-30 | $1.62B 10-Q · filed 2022-07-29 | |
| 2022-03-31 | $1.67B 10-Q · filed 2022-04-28 | |
| 2021-12-31 | $1.63B 10-K · filed 2023-02-13 | |
| 2021-09-30 | $582.70M 10-Q · filed 2021-10-29 | |
| 2021-06-30 | $382.00M 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $296.10M 10-Q · filed 2021-04-28 | |
| 2020-06-30 | $14.50M 10-Q · filed 2020-07-27 | |
| 2020-03-31 | $447.30M 10-Q · filed 2020-04-28 | |
| 2019-12-31 | $154.80M 10-K · filed 2021-02-12 | |
| 2019-06-30 | $237.00M 10-Q · filed 2019-07-26 | |
| 2019-03-31 | $355.60M 10-Q · filed 2019-04-26 | |
| 2018-12-31 | $503.60M 10-K · filed 2020-02-14 | |
| 2018-09-30 | $514.80M 10-Q · filed 2018-10-26 | |
| 2018-06-30 | $459.00M 10-Q · filed 2018-07-27 | |
| 2017-12-31 | $495.10M 10-K · filed 2019-02-15 | $504.80M 10-Q · filed 2018-07-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |